関連する実験動画
Updated: Sep 9, 2025

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
3.6K
ヒスタミンは,ヒトの肺のマスト細胞とマクロファージの交信を媒介する
Francesco Palestra1,2, Gina Memoli1,2, Agnese Secondo3
1Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Via S. Pansini 5, Naples, 80131, Italy.
Scientific reports
|August 30, 2025
まとめ
マスト細胞によって放出されるヒスタミンは,ヒト肺マクロファージ (HLM) に著しく影響します. 炎症を誘発するサイトカインの放出,反応性酸素種の産生を誘発し,呼吸道炎症における重要な細胞相互作用を強調し,オートファギーを阻害する.
科学分野:
- 免疫学
- 細胞生物学
- 呼吸器医学
背景:
- ヒスタミンはアレルギー反応の重要な媒介体であり,主にマスト細胞とベースフィルによって放出されます.
- アレルギー性疾患,特に人間の肺におけるマクロファージの役割は,しばしば過小評価されています.
- マクロファージはヒトの肺に豊富に存在し,マスト細胞に近い位置にあり,呼吸道炎症の潜在的相互作用を示唆する.
研究 の 目的:
- ヒト肺マクロファージ (HLM) の機能活動に対するヒスタミンの影響を調査する.
- マスト細胞によって潜在的に放出されるヒスタミンの役割を解明し,呼吸道炎症に関連するマクロファージの行動を調節する.
主な方法:
- 人間の肺組織 (HLM) からマクロファージを浄化する.
- ヒスタミン濃度の変化によるHLMの治療
- サイトカイン放出 (IL-6,TNF-α,IL-1β),mRNA発現,活性酸素種 (ROS) 産生,自殺過程,化学作用,およびH1受容体 (HRH1) 遺伝子発現の分析.
主要な成果:
- ヒスタミンは,炎症誘発性サイトカイン (IL-6,TNF-α,IL-1β) の濃度依存の放出を誘導し,HRH1経由でHLMにおけるIL-6 mRNAの発現を上昇させた.
- ヒスタミンはROSの産生を迅速に刺激し,HLMの自己消化過程を阻害した.
- ヒスタミンはまた,化学反応を誘導し,HLMの運動特性を変化させ,HRH1遺伝子発現を向上させた.
結論:
- ヒスタミンはヒトの肺マクロファージにおける複数の炎症誘発経路を活性化させ,呼吸道炎症における重要な役割を示唆している.
- この発見は,ヒスタミンがマクロファージの反応に影響を与える重要なシグナル分子の役割を果たすマスト細胞とマクロファージの相互作用の可能性を示しています.
- これらの結果は,アレルギー性呼吸道疾患の文脈でヒスタミンによるマクロファージの活性化を考慮する重要性を強調しています.
関連する概念動画
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Inflammation
55.1K
Overview
55.1K
Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
Allergic Reactions
28.5K
Overview
28.5K
Allergic Drug Reactions
972
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
972

